Related Experiment Video
Updated: Jul 16, 2026

The Assembly and Application of 'Shear Rings': A Novel Endothelial Model for Orbital, Unidirectional and Periodic Fluid Flow and Shear Stress
Published on: October 31, 2016
Minimal regulation of platelet activity by PECAM-1
Tarvinder S Dhanjal1, Ewan A Ross, Jocelyn M Auger
1Centre for Cardiovascular Sciences, Institute of Biomedical Research, Division of Medical Sciences, The Medical School, University of Birmingham, Birmingham B15 2TT, UK. t.s.dhanjal@bham.ac.uk
Abstract:
PECAM-1 is a member of the superfamily of immunoglobulins (Ig) and is expressed on platelets at moderate level. PECAM-1 has been reported to have contrasting effects on platelet activation by the collagen receptor GPVI and the integrin, alphaIIbbeta3, even though both receptors signal through Src-kinase regulation of PLCgamma2. The present study compares the role of PECAM-1 on platelet activation by these two receptors and by the lectin receptor, CLEC-2, which also signals via PLCgamma2. Studies using PECAM-1 knockout-mice and cross-linking of PECAM-1 using specific antibodies demonstrated a minor inhibitory role on platelet responses to the above three receptors and also under some conditions to the G-protein agonist thrombin. The degree of inhibition was considerably less than that produced by PGI2, which elevates cAMP. There was no significant difference in thrombus formation on collagen in PECAM-1-/- platelets relative to litter-matched controls. The very weak inhibitory effect of PECAM-1 on platelet activation relative to that of PGI2 indicate that the Ig-receptor is not a major regulator of platelet activation. PECAM-1 has been reported to have contrasting effects on platelet activation. The present study demonstrates a very mild or negligible effect on platelet activation in response to stimulation by a variety of agonists, thereby questioning the physiological role of the immunoglobulin receptor as a major regulator of platelet activation.
Insights
Platelet activation by key receptors is minimally affected by Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1). This study questions PECAM-1's role as a major regulator of platelet function.
Area of Science:
- Immunology
- Hematology
- Cellular Biology
Background:
- Platelet Endothelial Cell Adhesion Molecule-1 (PECAM-1), an immunoglobulin superfamily member, is expressed on platelets.
- Previous studies suggest PECAM-1 has contrasting effects on platelet activation pathways involving GPVI and alphaIIbbeta3 receptors.
Purpose of the Study:
- To investigate the role of PECAM-1 in platelet activation mediated by collagen receptor GPVI, integrin alphaIIbbeta3, and lectin receptor CLEC-2.
- To compare the inhibitory effect of PECAM-1 with prostacyclin (PGI2) and to assess its role in thrombus formation.
Main Methods:
- Utilized PECAM-1 knockout-mice and cross-linking antibodies to study platelet responses.
- Compared platelet activation and thrombus formation in PECAM-1 deficient platelets versus wild-type controls.
Main Results:
- PECAM-1 exhibited a minor inhibitory role in platelet activation by GPVI, alphaIIbbeta3, CLEC-2, and thrombin.
- The inhibitory effect of PECAM-1 was significantly less pronounced than that of PGI2.
- No significant difference in collagen-induced thrombus formation was observed between PECAM-1 knockout and control platelets.
Conclusions:
- PECAM-1 demonstrates a very mild or negligible effect on platelet activation by various agonists.
- The findings question the physiological significance of PECAM-1 as a major regulator of platelet activation.
More Related Videos
09:13Turbidimetry on Human Washed Platelets: The Effect of the Pannexin1-inhibitor Brilliant Blue FCF on Collagen-induced Aggregation
Published on: April 6, 2017
07:13Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Related Concept Videos
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Structure and Function of Platelets
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Regulation of Angiogenesis and Blood Supply